Related Experiment Video
Updated: Jun 12, 2026

Isolation and Differentiation of Stromal Vascular Cells to Beige/Brite Cells
Published on: March 28, 2013
PPAR gamma 2 prevents lipotoxicity by controlling adipose tissue expandability and peripheral lipid metabolism
Gema Medina-Gomez1, Sarah L Gray, Laxman Yetukuri
1Department of Clinical Biochemistry, Histopathology, University of Cambridge/Addenbrooke's Hospital, Cambridge, United Kingdom.
Abstract:
Peroxisome proliferator activated receptor gamma 2 (PPARg2) is the nutritionally regulated isoform of PPARg. Ablation of PPARg2 in the ob/ob background, PPARg2(-/-) Lep(ob)/Lep(ob) (POKO mouse), resulted in decreased fat mass, severe insulin resistance, beta-cell failure, and dyslipidaemia. Our results indicate that the PPARg2 isoform plays an important role, mediating adipose tissue expansion in response to positive energy balance. Lipidomic analyses suggest that PPARg2 plays an important antilipotoxic role when induced ectopically in liver and muscle by facilitating deposition of fat as relatively harmless triacylglycerol species and thus preventing accumulation of reactive lipid species. Our data also indicate that PPARg2 may be required for the beta-cell hypertrophic adaptive response to insulin resistance. In summary, the PPARg2 isoform prevents lipotoxicity by (a) promoting adipose tissue expansion, (b) increasing the lipid-buffering capacity of peripheral organs, and (c) facilitating the adaptive proliferative response of beta-cells to insulin resistance.
Insights
Peroxisome proliferator activated receptor gamma 2 (PPARg2) is crucial for managing fat storage and preventing insulin resistance. Its absence leads to metabolic dysfunction, highlighting its role in energy balance and cellular protection.
Area of Science:
- Metabolic Regulation
- Endocrinology
- Lipid Metabolism
Background:
- Peroxisome proliferator activated receptor gamma 2 (PPARg2) is a key nutritionally regulated isoform of PPARg.
- Understanding PPARg2's specific functions is vital for metabolic disease research.
Purpose of the Study:
- To investigate the specific role of the PPARg2 isoform in metabolic regulation, particularly in adipose tissue expansion and insulin resistance.
- To elucidate the antilipotoxic mechanisms mediated by PPARg2 in peripheral organs and its impact on beta-cell function.
Main Methods:
- Utilized PPARg2 knockout (PPARg2(-/-) Lep(ob)/Lep(ob)) mice (POKO mouse) to study gene ablation effects.
- Performed lipidomic analyses to assess lipid deposition and species in liver and muscle.
- Evaluated insulin resistance, beta-cell function, and overall metabolic phenotype.
Main Results:
- Ablation of PPARg2 in POKO mice led to decreased fat mass, severe insulin resistance, beta-cell failure, and dyslipidemia.
- PPARg2 facilitates adipose tissue expansion in response to positive energy balance.
- Ectopic PPARg2 expression in liver and muscle promoted fat deposition as triacylglycerol, preventing reactive lipid accumulation and exhibiting an antilipotoxic role.
- PPARg2 appears necessary for the adaptive hypertrophic response of beta-cells to insulin resistance.
Conclusions:
- The PPARg2 isoform is essential for preventing lipotoxicity through multiple mechanisms.
- These mechanisms include promoting adipose tissue expansion, enhancing lipid buffering in peripheral organs, and supporting beta-cell adaptation to insulin resistance.
More Related Videos
Related Concept Videos
Cell Specific Gene Expression
GPCRs Regulate Adenylyl Cylase Activity
Two...
Transducer Mechanism: Nuclear Receptors
About 48 different soluble family members of nuclear receptors are identified that can be divided into two main classes:
Overview of Lipid Metabolism
Lipolysis: The Breakdown of Lipids:
Lipolysis is the process of breaking down lipids, particularly triglycerides, into glycerol and fatty acids. This process typically occurs in the adipose tissue and is triggered by various hormones, including glucagon and...
Cholesterol: Significance and Regulation
Considering cholesterol and...
Glucagon-like Receptor Agonists
GLP-1, when administered in high doses intravenously, triggers insulin secretion, inhibits glucagon release, slows gastric emptying, reduces food intake, and restores normal insulin secretion. However, its rapid inactivation by the...

